Related Experiment Video
Updated: Oct 16, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Mild left ventricular hypertrophy in essential hypertension: is it really arrhythmogenic?
K A Gatzoulis1, G P Vyssoulis, T Apostolopoulos
1University Cardiology Division, Hippokration General Hospital, Athens, Greece.
Insights
Mild left ventricular hypertrophy (LVH) in early hypertension does not increase arrhythmia risk. Antihypertensive therapy can reverse LVH without additional antiarrhythmic treatment.
Area of Science:
- Cardiology
- Hypertension Research
- Electrophysiology
Background:
- Left ventricular hypertrophy (LVH) is linked to arrhythmias and sudden cardiac death in hypertensive patients.
- The association between mild LVH and arrhythmias in early, asymptomatic hypertension is not well-established.
Purpose of the Study:
- To investigate the arrhythmogenic risk associated with mild LVH in early asymptomatic hypertensive patients.
- To assess the impact of antihypertensive treatment on LVH and arrhythmia incidence.
Main Methods:
- Prospective study of 100 consecutive essential hypertensive patients (35 without LVH, 65 with mild LVH).
- Comprehensive noninvasive arrhythmia evaluation including signal-averaged ECG.
- Follow-up for 3 +/- 1 years in an ambulatory hypertension clinic.
Main Results:
- No significant differences in ECG parameters or simple ventricular ectopy between hypertensive groups.
- Complex ventricular ectopy was rare in both groups.
- Mild LVH did not correlate with increased arrhythmia risk or symptoms during follow-up.
- Antihypertensive treatment led to LVH regression.
Conclusions:
- Mild LVH in ambulatory hypertensive patients does not appear to confer an additional arrhythmogenic risk.
- Appropriate antihypertensive therapy can reverse mild LVH effectively.
- Additional antiarrhythmic management is not necessary for mild LVH in this patient group.
Abstract:
Left ventricular hypertrophy (LVH) has been associated with an increased incidence of ventricular arrhythmias and sudden cardiac death in hypertensive patients. However, it is not known whether this relationship exists in early asymptomatic hypertensives with mild LVH. We prospectively examined 100 consecutive patients with essential hypertension, 35 without and 65 with mild LVH on echocardiography. All underwent a detailed noninvasive arrhythmia work-up and were subsequently followed-up for 3 +/- 1 years in an ambulatory hypertension clinic. None of the 12-lead electrocardiographic parameters examined differed between the two hypertensive groups. A similarly low incidence of simple forms of ventricular ectopy was present in both groups, whereas complex forms of ventricular ectopy were extremely rare in either group. The signal-averaged electrocardiographic parameters examined were also not significantly affected by the presence of mild LVH. Arrhythmia-related symptoms or malignant ventricular arrhythmia events were not observed in either group of patients during follow-up with antihypertensive treatment. The latter resulted in LVH regression in the 65 patients with mild LVH at baseline. It appears that mild LVH among ambulatory hypertensive patients does not carry an additive arrhythmogenic risk and can be successfully reversed with the appropriate antihypertensive therapy, with no need of additional antiarrhythmic management.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology
Mitral Stenosis I: Introduction
Cardiomyopathy I: Introduction and Classification
Pathophysiology of Heart Failure

